Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.
about
Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis.The expression of Bcl-2 and BID in gastric cancer cells.Inhibition of green tea polyphenol EGCG((-)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical wnt/β-catenin signalling pathway.
P2860
Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.
@en
Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.
@nl
type
label
Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.
@en
Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.
@nl
prefLabel
Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.
@en
Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.
@nl
P2093
P2860
P1476
Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.
@en
P2093
Cristóbal Belda
César Gómez
Enrique Casado
Jaime Feliu
Javier De Castro
María Sereno
Miguel Angel García-Cabezas
Miriam López
Paloma Cejas
P2860
P2888
P304
P356
10.1007/S12029-011-9267-Z
P577
2012-06-01T00:00:00Z